Bluejay Diagnostics (BJDX) Total Non-Current Liabilities (2020 - 2026)

Bluejay Diagnostics has disclosed Total Non-Current Liabilities across 6 years of filings, most recently posting $1.4 million for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $1.4 million, up 0.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (up 0.7% YoY), and the FY2025 annual result was $1.1 million, up 23.94% from the prior year.
• Total Non-Current Liabilities came in at $1.4 million for Q1 2026 at Bluejay Diagnostics, up from $1.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $3.0 million in Q3 2023 to a low of $919357.0 in Q4 2024.
• The 5-year median for Total Non-Current Liabilities is $1.7 million (2024), against an average of $1.7 million.
• Across the five-year window, Total Non-Current Liabilities surged 60.72% in 2023 and tumbled 60.95% in 2024, its largest moves.
• Bluejay Diagnostics' Total Non-Current Liabilities stood at $2.0 million in 2022, then retreated by 0.14% to $2.0 million in 2023, then tumbled by 53.13% to $919357.0 in 2024, then rose by 23.94% to $1.1 million in 2025, then climbed by 24.09% to $1.4 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $1.4 million (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.